S. Demotz

发表

Tuning of T Cell Clone Size and Activation Threshold by Control of CD25 Expression through Mitogen-Activated Protein Kinase Pathways

Christina Bitegye, S. Hannier, S. Guérif, 2002, International Archives of Allergy and Immunology.

Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies*

L. Willen, P. Schneider, A. Tardivel, 2011, The Journal of Biological Chemistry.

Biological Activity of Ectodysplasin A Is Conditioned by Its Collagen and Heparan Sulfate Proteoglycan-binding Domains*

L. Willen, P. Schneider, A. Tardivel, 2009, The Journal of Biological Chemistry.

Native-like, long synthetic peptides as components of sub-unit vaccines: practical and theoretical considerations for their use in humans.

S. Demotz, N. Fasel, S. Masina, 2001, Molecular immunology.

The relative abundance of two measles virus fusion protein peptide-DR1 complexes expressed by B cells is independent of the form of the antigen.

S. Demotz, 1999, Cellular immunology.

4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.

V. Zoete, S. Demotz, R. Marti, 2018, Bioorganic & medicinal chemistry.

(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.

K. Higaki, S. Demotz, P. Burda, 2017, European journal of medicinal chemistry.

Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia.

P. Schneider, A. Tardivel, K. Ingold, 2007, American journal of human genetics.

Cell type‐specific processing of the I‐Ed‐restricted hen egg lysozyme determinant 107–116

S. Demotz, H. Wallny, C. Robadey, 1996, European journal of immunology.

Presentation of self-peptides: consequences for self nonself discrimination and allorecognition.

A. Lanzavecchia, S. Demotz, 1993, International reviews of immunology.

Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes.

S. Demotz, K. E. El Kasmi, C. Muller, 2000, Journal of immunological methods.

Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.

S. Demotz, C. Danieli, 1993, Molecular immunology.

DR αβ dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones

S. Demotz, 1993 .

A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.

S. Demotz, N. Beltraminelli, N. Fasel, 2004, Vaccine.

N‐Alkyl‐, 1‐C‐Alkyl‐, and 5‐C‐Alkyl‐1,5‐dideoxy‐1,5‐imino‐(l)‐ribitols as Galactosidase Inhibitors

S. Demotz, O. Martin, Estelle Gallienne, 2016, ChemMedChem.

A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants

S. Demotz, P. Greaney, M. Schapira, 2011, Blood cancer journal.

Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways.

S. Demotz, A. Péléraux, 1996, Molecular immunology.

Inhibition of peptide binding to DR molecules by a leupeptin-induced invariant chain fragment.

O. Majdic, S. Demotz, H. Wallny, 1994, Molecular immunology.

A novel and simple procedure for determining T cell epitopes in protein antigens.

P. Matricardi, A. Lanzavecchia, S. Demotz, 1989, Journal of immunological methods.

Studies on the nature of physiologically processed antigen and on the conformation of peptides required for interaction with MHC.

H. Grey, A. Sette, S. Buus, 1989, Cold Spring Harbor Symposia on Quantitative Biology.

Early Events of TCR Signaling Are Distinct in Human Th1 and Th2 Cells

Christina Bitegye, S. Hannier, S. Demotz, 2002, The Journal of Immunology.

This information is current as Human Th 1 and Th 2 Cells Early Events of TCR Signaling Are Distinct in

Christina Bitegye, S. Hannier, S. Demotz, 2002 .

Kinetics of MHC-antigen complex formation on antigen-presenting cells.

A. Lanzavecchia, S. Demotz, G. Corradin, 1988, Journal of immunology.

Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway.

F. Martinon, S. Valitutti, S. Demotz, 1999, Journal of immunology.

Self peptide requirement for class II major histocompatibility complex allorecognition.

H. Grey, A. Sette, K. Sakaguchi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens.

B. Gander, H. Merkle, G. Eberl, 1999, Vaccine.

Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.

S. Demotz, A. Thierry, C. Moulon, 2006, European cytokine network.

Biotinylated Synthetic Chemokines: Their Use for the Development of Nonradioactive Whole-Cell Binding Assays

S. Demotz, S. Pinaud, A. Thierry, 2003, Journal of biomolecular screening.

Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.

P. Matricardi, P. Panina, A. Lanzavecchia, 1989, Journal of immunology.

A Fas agonist induces high levels of apoptosis in haematological malignancies.

Isabelle Bassi, S. Demotz, P. Greaney, 2006, Leukemia research.

Calpain Proteolytic Pathway Stimulation in Human T Lymphocytes : Role Degradation of ZAP-70 Following Antigenic

F. Martinon, S. Demotz, S. Müller, 1999 .

Antigen presenting cells: detection and quantification of a cytochrome c determinant important for activation of T-cells on bone marrow derived macrophages by using specific anti cytochrome c monoclonal antibody.

C. Vita, S. Demotz, G. Corradin, 1987, Advances in experimental medicine and biology.

Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen.

S. Demotz, N. Fasel, S. Masina, 2003, The Journal of infectious diseases.

Iminosugar-C-glycosides work as pharmacological chaperones of NAGLU, a glycosidase involved in MPS IIIB rare disease.

S. Demotz, D. Alonzi, T. Butters, 2021, Chemistry.

Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme

H. Grey, A. Sette, E. Appella, 1989, Nature.

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86

Antonio Lanzavecchia, Antonio Amoroso, A. Lanzavecchia, 1993, European journal of immunology.

Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints, degenerate binding, and promiscuous recognition.

A. Lanzavecchia, S. Demotz, P. Panina-Bordignon, 1989, Cold Spring Harbor symposia on quantitative biology.

The minimal number of class II MHC-antigen complexes needed for T cell activation.

H. Grey, A. Sette, S. Demotz, 1990, Science.

Delineation of several DR-restricted tetanus toxin T cell epitopes.

A. Lanzavecchia, C. Widmann, S. Demotz, 1989, Journal of immunology.

Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles

S. Demotz, C. Balmelli, P. De Grandi, 2002, Journal of Virology.

Epitope mapping by chemical modification of free and antibody-bound protein antigen.

H. Binz, H. Bosshard, S. Demotz, 1987, Science.

Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules.

S. Demotz, G. Corradin, G Corradin, 1997, Human immunology.

Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension.

J. Haefliger, P. Meda, S. Demotz, 2001, Kidney international.

Long synthetic peptides as biologically active proteins: the example of the chemokines.

S. Demotz, S. Pinaud, N. Fasel, 2001, Biologicals : journal of the International Association of Biological Standardization.

The processing routes determined by negatively charged residues in DR1-restricted T cell determinants.

J. Haefliger, R. Sékaly, S. Demotz, 1997, Journal of immunology.

Kinetics and extent of protein tyrosine kinase activation in individual T cells upon antigenic stimulation

S. Valitutti, S. Demotz, S. Müller, 1999, Immunology.

Mapping of T Cell Epitopes in Proteins: A Chemical Approach

A. Lanzavecchia, S. Demotz, G. Corradin, 1990 .